Protocol No.: VRDN-003-301
- Title
- A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with active thyroid eye disease (TED) Reveal 1
- Principal Investigator
- Nguyen, John
- Phase
- II/III
- Age Group
- Adult
- Applicable Disease Site
- Other
- Participating Institutions
- Eye Institute
- West Virginia University
- Contacts
- Athena Echols
- Clinical Trials Coordinator
- Phone: +1 304-598-6977
- Email: athena.sparks@wvumedicine.org
- Christina Sundar, CRC
- Clinical Research Coordinator
- Phone: +1 304-598-6956
- Email: christina.sundar1@wvumedicine.org
- Emalee Taylor
- Certified Ophthalmic Assistant
- Email: emalee.taylor@wvumedicine.org